← Eichor
Study identifier: NCT06501092 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

To Assess the Utility of the Point Mini in a Clinical Take-home Study

Condition: Amputation; Traumatic, Hand · Amputation, Congenital  ·  Sponsor: Point Designs

PhaseNA
Planned participants14
Who can joinAll sexes, 3 Years to 17 Years
Healthy volunteersNo

About this study

The objective of this study is to evaluate the efficacy of the Point Mini system as compared to the subject's existing prosthetic treatment, which may include a prosthesis, other assistive device, or no device. This study will be a single subject crossover design where one group of 14 children with partial hand deficiencies will be evaluated on several metrics using their existing prosthetic treatment for one month and the Point Mini system for two months. Metrics include: in-clinic functional measures, subjective assessments, bilateral hand use, and prosthesis wear time.

This description comes directly from the study's public registry record.

Talk to the study team

Rebecca Connolly  ·  720-600-4753  ·  becca@pointdesigns.com

Levin Sliker, PhD  ·  720-600-4753  ·  levin@pointdesigns.com

Always discuss trial participation with your own doctor first.

Locations (2)

Point DesignsLafayette, Colorado, United StatesNot Yet Recruiting
Children's Healthcare of AtlantaAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06501092